Our Reimbursement, Health Economics & Market Access Experience
Bringing innovative medical technologies to market requires more than just groundbreaking science—it demands a nuanced understanding of stakeholder expectations, market dynamics, policy requirements, and commercialization strategy. MCRA's RHEMA team, filled with experienced healthcare reimbursement consultants, boasts deep expertise across a wide variety of capabilities allowing your company to gain a strategic partner committed to navigating the intricate healthcare landscape and ensuring the success of your product throughout its lifecycle.
Our Integrated Approach
Bringing innovative medical technologies to market requires more than just groundbreaking science—it demands a nuanced understanding of stakeholder expectations, market dynamics, policy requirements, and commercialization strategy. MCRA's RHEMA team boasts deep healthcare reimbursement consulting expertise across a wide variety of capabilities allowing your company to gain a strategic partner committed to navigating the intricate medical device reimbursement landscape and ensuring the success of your product throughout its lifecycle.
MCRA’s medical device reimbursement consultants understand that issues such as tight financing, inadequate time, competition, and complex regulatory and reimbursement requirements require your company to rapidly commercialize your technology. The RHEMA team takes a holistic approach, beginning early in the product lifecycle to develop sound strategies for future success.
Prior to product commercialization, RHEMA offers strategic guidance in reimbursement, evidence development, and market opportunity. This involves development of strategic approaches for collecting essential clinical and health economic data, recommendations for coverage, coding, and payment pathways, and identification of market opportunities for product entry and growth. During clinical trials, we collaborate with and advise individual sites, management, and payors on the availability of appropriate coverage and reimbursement pathways, and we advise on inclusion of study design elements that will help to yield successful reimbursement.
Our MedTech reimbursement consulting services help you prepare for successful product launch by submitting coding and payment applications, acquiring market data, preparing billing and coding guides, developing real world evidence, and providing product value communication materials like value dossiers and budget impact models. After product launch, RHEMA can work with you to grow your market by facilitating payer engagement and case-by-case appeals through our patient access program.
Our dedicated healthcare reimbursement consultants are committed to strong client partnership and collaboration to ensure alignment of goals and to guide you through the complexities of reimbursement, ensuring your innovations thrive in the competitive medical technology landscape.
